Skip to content

TriSalus Life Sciences (TLSI) via MedTech Acq (MTAC) deck

TriSalus Life Sciences® is an oncology therapeutics company integrating immunotherapy with disruptive delivery technology to transform the treatment paradigm for patients with liver and pancreatic tumors.

This post is for subscribers only


Already have an account? Sign In